The trademark application LINC-Ig was filed by CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.), a corporation established under the laws of Japan (the "Applicant"). The application was published for oppositions on August 9, 2021, and it was registered by office on November 16, 2021 without any oppositions.
The application was filed in English (Spanish was selected as the second language).
Change of name and professional address of the trademark registration was recorded on February 2, 2022.
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations for human use, namely, pharmaceutical antibodies or its fragments or its derivatives, cells and genes that produces antibodies, fragments of antibodies or derivatives of antibodies for medical and pharmaceutical use.
The mark was filed in class 42 with Pharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticals.
The mark was filed in class 45 with Granting of licenses to others for the use of industrial property rights and copyright.